and ETFs to compile a list of 25 pharma stocks. We then selected the top 11 with the highest number of hedge fund holders as ...

Finally, the stocks were arranged in ascending order of their hedge fund sentiments ... 150 percentage points (see more details here). A pharmaceutical plant manufacturing a proprietary synthetic ...

Still, there have been impacts on companies that particularly service the pharmaceutical ... is sorted in ascending order of analysts’ average upside potential. These stocks are also popular ...

While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about ...

Learn more about whether Kymera Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's ...

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

However, the stock was also likely negatively impacted by CNBC Mad Money host Jim Cramer's comments on Friday. He expressed reservations about buying shares of Recursion Pharmaceuticals in light ...

BIOMARIN PHARMACEUTICAL ($BMRN) posted quarterly earnings results on Wednesday, February 19th. The company reported earnings of $0.92 per share, beating estimates of ...

Small biotech stocks usually aren't a great fit for risk-averse investors. However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some ...